Impact Of DRGs On Clinical Research Less Than First Feared, Speakers Tell NIH Directors Meeting
In Brief: Calabresi Named DCT Board Chairman; NCI Gets $5 Million Gifts for Intramural Breast Cancer Work
Organ Systems Program Finally Loses a Couple, But Gets OK for Breast Cancer Risk Study RFA
Other Concepts Approves By DCE Board Last Week
New Cancer Education Program “Striking Change,” To Fund CR, Prebaccalaureate, Summer Training
Adamson Rips “Rip Van Bailer”
Trending Stories
- Right-wing provocateur Laura Loomer comes for FDA’s Vinay Prasad
- FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts
- U.S. News & World Report expands evaluation of outcomes in cancer subspecialties
- GOP-led Congress rejects Trump’s plans to gut medical research
Senate bill gives NIH a $400 million raise - Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director
His appointment came out of “proximity” to Makary and Bhattacharya - Vinay Prasad falls from grace at FDA upon flunking Trump political purity test
MAHA leaders agree on one point: COVID was mishandled. Is that enough to run science-based agencies?